Prephase steroid use and association with dose delays and outcomes in a real-world cohort of older adults treated for diffuse large B-cell lymphoma

被引：0
|
作者：
Vartanov, Alexander R. [1 ]
Hasler, Jill S. [2 ]
Handorf, Elizabeth A. [2 ,3 ]
Frosch, Zachary A. K. [4 ,5 ]
机构：
[1] Fox Chase Canc Ctr, Dept Bone Marrow Transplant & Cellular Therapy, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA USA
[3] Rutgers Sch Publ Hlth, Biostat & Epidemiol Facil, Piscataway, NJ USA
[4] Fox Chase Canc Ctr, Dept Hematol Oncol, Philadelphia, PA USA
[5] Fox Chase Canc Ctr, Canc Prevent & Control Res Program, Philadelphia, PA USA
来源：
LEUKEMIA & LYMPHOMA | 2025年
关键词：
ELDERLY-PATIENTS; R-CHOP; CHEMOTHERAPY; INTENSITY; TRIAL;
D O I：
10.1080/10428194.2025.2450091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    BLOOD, 2023, 142 (12) : 1047 - 1055
  • [32] Real-World Experience of Pola-R-CHP Therapy in Diffuse Large B-Cell Lymphoma Aged 80 or Older
    Kanemura, Nobuhiro
    Yamada, Toshiki
    Goto, Hideko
    Hara, Takeshi
    Kasahara, Senji
    Fukuno, Kenji
    Sawada, Michio
    Nakamura, Hiroshi
    Nakamura, Nobuhiko
    Lee, Shin
    Fujita, Kei
    Suzaki, Tomomi
    Hayase, Naoki
    Goto, Takayuki
    Shimizu, Masahito
    Tsurumi, Hisashi
    BLOOD, 2024, 144 : 3089 - 3090
  • [33] Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine
    Young, Christina
    Burningham, Zachary
    Schulz, Mathias
    Li, Jia
    Masaquel, Anthony
    Halloran, Mary
    Delong-Sieg, Elisha
    Sauer, Brian C.
    BLOOD, 2018, 132
  • [34] RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD NATIONWIDE COHORT STUDY
    Ko, B. S.
    Huang, H. H.
    Wang, C. Y.
    Chen, H. M.
    Hsiao, F. Y. S.
    VALUE IN HEALTH, 2019, 22 : S435 - S435
  • [35] Trial in Progress: Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Systemic Therapy from Real-World Experience (ORCHID)
    Thieblemont, Catherine
    Ma, Qiufei
    Hampp, Christian
    Harnett, James
    Sober, Rachel E.
    Jalbert, Jessica J.
    Quek, Ruben G. W.
    Wei, Wenhui
    Wu, Ning
    Mastey, Vera
    Wang, Joy
    Bajwa, Anit
    Maissenhaelter, Benedikt
    van Gils, Chantal
    Aggarwal, Shivani
    Chaudhry, Aafia
    Mohamed, Hesham
    Ambati, Srikanth R.
    Bachy, Emmanuel
    Damaj, Gandhi Laurent
    BLOOD, 2022, 140 : 8065 - 8067
  • [36] IMPACT OF DOSE INTENSITY IN OLDER PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Warley, Fernando
    Kalmus, Mariana
    Cristaldo, Nancy
    Ismael, Ileana l.
    Boietti, Bruno
    Smietniansky, Maximiliano
    MEDICINA-BUENOS AIRES, 2023, 83 (05) : 854 - 856
  • [37] Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
    Sineshaw, Helmneh M.
    Zettler, Christina M.
    Prescott, Jennifer
    Garg, Mahek
    Chakraborty, Samhita
    Sarpong, Eric M.
    Bai, Claire
    Belli, Andrew J.
    Fernandes, Laura L.
    Wang, Ching-Kun
    CANCER MEDICINE, 2024, 13 (07):
  • [38] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SEER-MEDICARE ANALYSIS
    Hamlin, P.
    Satram-Hoang, S.
    Reyes, C.
    Hoang, K.
    Guduru, S.
    Skettino, S.
    HAEMATOLOGICA, 2013, 98 : 353 - 353
  • [39] Real-World Outcomes of Consolidative Autotransplant for High-Risk Large B-Cell Lymphoma
    Puckrin, Robert
    Sterrett, Russell
    Chua, Neil
    Owen, Carolyn
    Duggan, Peter
    Shafey, Mona
    Stewart, Douglas A.
    BLOOD, 2022, 140 : 10581 - 10582
  • [40] Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Qualls, David A.
    Lambert, Nicholas
    Caimi, Paolo F.
    Merrill, Mwanasha
    Pullarkat, Priyanka
    Godby, Richard C.
    Bond, David A.
    Wehmeyer, Graham T.
    Romancik, Jason
    Amoozgar, Behzad
    Leslie, Lori
    Nastoupil, Loretta J.
    Crombie, Jennifer L.
    Abramson, Jeremy S.
    Khurana, Arushi
    Nowakowski, Grzegorz S.
    Maddocks, Kami
    Rutherford, Sarah C.
    Kahl, Brad
    Okwali, Michelle
    Buege, Michael J.
    Seshan, Venkatraman
    Batlevi, Connie L.
    Salles, Gilles
    BLOOD, 2023, 142 (26) : 2327 - 2331
12345